Inventor
ZUBOV DMITRY
DE17 patents
⚠️ This page may combine multiple inventors who share the name “ZUBOV DMITRY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BAYER AG
7 patentsUS6835381B1Dec 28, 2004
Methods for modulating angiogenesis by using the anti-angiogenic angiotensin-7 and polynucleotides encoding therefor
BAYER AG8 citations65
US10722501B2Jul 28, 2020
Substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-A]pyridine-3(2H)-ones and 2,5,6,7-tetrahydro-3H-pyrrolo[2,1-C][1,2,4]triazol-3-ones, and use thereof
BAYER AG2 citations58
US12503491B2Dec 23, 2025
MASP inhibitory compounds and uses thereof
BAYER AG0 citations56
US11667675B2Jun 6, 2023
MASP inhibitory compounds and uses thereof
BAYER AG0 citations56
US11337973B2May 24, 2022
Substituted [1,2,4]triazolo[4,3-A]pyrazines as prolyl endopeptidase inhibitors
BAYER AG0 citations46
US6808883B1Oct 26, 2004
Automatable rapid test for detection of cancer, based on telomerase (hTC) mRNA with specific primers and probes
BAYER AG0 citations46
US12398120B2Aug 26, 2025
Substituted hydantoinamides as ADAMTS7 antagonists
BAYER AG0 citations43
Bayer Pharma AG
6 patentsUS10300062B2May 28, 2019
Bicyclically substituted uracils and the use thereof
Bayer Pharma AG11 citations92
US9481672B2Nov 1, 2016
Bicyclically substituted uracils and the use thereof
Bayer Pharma AG18 citations92
US9949978B2Apr 24, 2018
Bicyclically substituted uracils and the use thereof
Bayer Pharma AG12 citations83
US9949977B2Apr 24, 2018
Bicyclically substituted uracils and the use thereof
Bayer Pharma AG12 citations83
US9751843B2Sep 5, 2017
Substituted uracils and use thereof
Bayer Pharma AG2 citations73
US9695131B2Jul 4, 2017
Substituted uracils as chymase inhibitors
Bayer Pharma AG2 citations72